Management of these toxicities emanates from accurate diagnosis and grading of adverse events, appropriate clinical investiga- tion and immunosuppression, followed-up with surveillance of any immunosuppressive management after 72 h [64]. Early involvement of relevant specialist physicians is often necessary...